ZIVO Bioscience, Inc. (ZIVO) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
ZIVO Bioscience, Inc. (ZIVO) Bundle
Explore ZIVO Bioscience, Inc. (ZIVO) financial prospects using our user-friendly DCF Calculator! Enter your assumptions for growth, margins, and expenses to calculate the intrinsic value of ZIVO and enhance your investment approach.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | -100 | 0 | 0 | -25 | -25 | -25 | -25 | -25 |
| EBITDA | -8.4 | -.6 | -9.1 | -8.7 | -7.3 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | -2750.27 | 100 | 100 | -26267.67 | 20 | 20 | 20 | 20 | 20 |
| Depreciation | 8.4 | 8.6 | -.4 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 42778.38 | 100 | 100 | 0 | 80 | 80 | 80 | 80 | 80 |
| EBIT | -16.7 | -9.1 | -8.6 | -8.7 | -7.3 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | -45528.64 | 100 | 100 | -26267.67 | 20 | 20 | 20 | 20 | 20 |
| Total Cash | .3 | .1 | 8.9 | 1.8 | .3 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 0 | 100 | 100 | 13.51 | 62.7 | 62.7 | 62.7 | 62.7 | 62.7 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 0 | 100 | 100 | 0 | 60 | 60 | 60 | 60 | 60 |
| Accounts Payable | 1.4 | 1.6 | .7 | .5 | 1.2 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 7798.14 | 100 | 100 | 4216.13 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -21.3 | -9.7 | -8.9 | -8.7 | -7.3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -11.6 | -.9 | -10.2 | -8.9 | -6.6 | -1.1 | .0 | .0 | .0 | .0 |
| WACC, % | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -1 | |||||||||
| Diluted Shares Outstanding, MM | 2 | |||||||||
| Equity Value Per Share | -0.60 |
What You Will Get
- Real ZIVO Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for ZIVO Bioscience, Inc. (ZIVO).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates specific to ZIVO.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on ZIVO’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections for ZIVO.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility in your analysis of ZIVO.
Key Features
- Comprehensive Data: ZIVO's historical performance metrics and pre-filled projections.
- Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Insights: Observe ZIVO’s intrinsic value update instantly.
- Intuitive Visualizations: Dashboard graphs showcase valuation outcomes and essential metrics.
- Designed for Precision: An expert tool tailored for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered ZIVO data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for ZIVO’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for ZIVO Bioscience, Inc. (ZIVO)?
- Accurate Data: Utilize real ZIVO financials for dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Built-in calculations save you from starting from scratch.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Easy-to-navigate design and clear instructions ensure accessibility for all users.
Who Should Use This Product?
- Investors: Evaluate ZIVO’s market position before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess future forecasts.
- Startup Founders: Understand the valuation strategies of successful biotech companies like ZIVO.
- Consultants: Provide detailed valuation analyses for clients in the biotech sector.
- Students and Educators: Utilize current data to learn and teach valuation principles in biotechnology.
What the Template Contains
- Preloaded ZIVO Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.